Hear experts' takeaways from ACOG 2025 on menopause care, postpartum depression screening, and obesity management.
Nanette F Santoro, MD
Advertisement
Articles by Nanette F Santoro, MD
The nonhormonal neurokinin-3 receptor antagonist improved menopausal adiposity without appreciable impact on body weight or BMI, Santoro explained at 2025 ACOG meeting.
Advertisement
Latest Updated Articles
Women’s Health Takeaways for Primary Care: Expert Insights From ACOG 2025Published: June 6th 2025 | Updated:
Nanette Santoro, MD, Highlights Findings on Fezolinetant From Pooled Analysis of Phase 3 Skylight Development Program TrialsPublished: May 19th 2025 | Updated:
Advertisement
Advertisement
Trending on Patient Care Online
1
Colorectal Cancer Becomes Leading Cause of Cancer Death in US Adults Younger Than 50 Years, Study Finds
2
Centanafadine Granted FDA Priority Review for the Treatment of ADHD Across Pediatric and Adult Populations
3
Investigational Dual GLP-1/GIP Agonist CT-388 Demonstrates 22.5% Placebo-Adjusted Weight Loss in Phase 2 Obesity Trial
4